Format

Send to

Choose Destination
See comment in PubMed Commons below
Infect Immun. 2008 May;76(5):2025-36. doi: 10.1128/IAI.00105-08. Epub 2008 Mar 17.

Yersinia pestis caf1 variants and the limits of plague vaccine protection.

Author information

  • 1Department of Microbiology, University of Chicago, Chicago, Illinois 60637, USA.

Abstract

Yersinia pestis, the highly virulent agent of plague, is a biological weapon. Strategies that prevent plague have been sought for centuries, and immunization with live, attenuated (nonpigmented) strains or subunit vaccines with F1 (Caf1) antigen is considered effective. We show here that immunization with live, attenuated strains generates plague-protective immunity and humoral immune responses against F1 pilus antigen and LcrV. Y. pestis variants lacking caf1 (F1 pili) are not only fully virulent in animal models of bubonic and pneumonic plague but also break through immune responses generated with live, attenuated strains or F1 subunit vaccines. In contrast, immunization with purified LcrV, a protein at the tip of type III needles, generates protective immunity against the wild-type and the fully virulent caf1 mutant strain, in agreement with the notion that LcrV can elicit vaccine protection against both types of virulent plague strains.

PMID:
18347051
PMCID:
PMC2346721
DOI:
10.1128/IAI.00105-08
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center